Audio Journal of Oncology Podcast Hassan Mohammed Abushukair MD; AACR 2026: Immune Checkpoint Inhibitor-Induced Myocarditis within One Month Predicts Lethal “Triple M Overlap Syndrome” Play Episode Pause Episode 1x 00:00 / 00:10:44 Subscribe Apple...
RAS G12 Targeting Drug Daraxonrasib Doubles Survival with Pancreas Cancer in Phase 3 RASolute 302 Study An interview with: Eileen M O’Reilly MD, Medical Oncologist, Professor of Medicine, Winthrop Rockefeller Chair in Medical Oncology and Leader of...
Audio Journal of Oncology Podcast Omar Nadeem MD 2026 AACR: BCMA-directed CAR T-cell Therapy Highly Effective In Patients with High-Risk Smoldering Multiple Myeloma Play Episode Pause Episode 1x 00:00 / 00:10:55 Subscribe Apple Podcasts Spotify RSS...
Audio Journal of Oncology Podcast Ahmad A Tarhini MD PhD, AACR 2026: Molecular Glue Brings New Hope for Patients with BRAF or NRAS-Mutant Melanoma or Other RAS/RAF-driven Malignancies Play Episode Pause Episode 1x 00:00 / 00:08:25 Subscribe Apple...
Wildfire Smoke Pollution Associated with Increased Lung, Colorectal, Breast, Bladder and Hematopoietic Cancer Rates An interview with: Shuguang Leng MBBS PhD, Associate Professor, University of New Mexico Comprehensive Cancer Center, Albuquerque...
Audio Journal of Oncology Podcast Rukhmini Bandyopadhyay MD, AACR 2026: AI “Pathomics Platform” Selects Immunotherapy, Predicts Outcome for Patients with Metastatic Non-Small Cell Lung Cancer Play Episode Pause Episode 1x 00:00 / 00:10:14 Subscribe...
Audio Journal of Oncology Podcast Jonathan Wesley Riess MD; 2026 AACR: Investigational KRAS(ON) Inhibitor Zoldonrasib Showed Effective and Durable Responses in Patients With Advanced G12D-mutated Lung Cancer Play Episode Pause Episode 1x 00:00 /...
Audio Journal of Oncology Podcast Marija Balic MD PhD, AACR 2026: Whole Exome Sequencing of ctDNA Informs Post-Neoadjuvant Therapy Options for Patients with Triple Negative Early Breast Cancer Play Episode Pause Episode 1x 00:00 / 00:10:30 Subscribe...
Anti-Claudin 6 Antibody Drug Conjugate Benefits Patients with Advanced Platinum-Resistant Ovarian Cancer with Low Toxicity An interview with: Tao Zhu, MD, Chief Physician and Vice President, Zhejiang Cancer Hospital, China SAN DIEGO, USA— The...
Oral Intralesional PD 1 Blockade Promises Less Risk of Progression to Oral Cancer than Surgery, with Preserved Quality of Life An interview with: Moran Amit MD PhD, Head and Neck Surgeon, Assistant Professor, University of Texas MD Anderson Cancer...
Audio Journal of Oncology Podcast Byoung Chul Cho MD PhD; AACR 2026: New Generation KRAS G12C Inhibitor Brings Promising Responses Even in Patients with Advanced Lung Cancers Refractory to Previous KRAS-targeted Therapy Play Episode Pause Episode 1x...
Audio Journal of Oncology Podcast Elena Garralda MD PhD, AACR 2026: Molecular Glue Degrader Improves Outcomes in Heavily Pre-treated Patients with Advanced Solid Tumors Play Episode Pause Episode 1x 00:00 / 00:08:38 Subscribe Apple Podcasts Spotify...

